Getting to 80% ART coverage Dr Francois Venter Reproductive Health and HIV Research Unit University of the Witwatersrand January 2010 Thanks to: Robin.

Slides:



Advertisements
Similar presentations
HIV/AIDS in Ethiopia Daniel Yilma Jimma Univeristy, Ethiopia.
Advertisements

High Rates of Tuberculosis in Patients Accessing HAART in Rural South Africa – Implications for HIV and TB Treatment Programs Kogieleum Naidoo on behalf.
The new guidelines Dr Francois Venter Reproductive Health and HIV Research Unit University of the Witwatersrand Feb 2010.
Early Infant Diagnosis: Challenges and Solutions A special session IAS, Vienna 2010.
Dr Susan Zimba –Tembo Professional Officer – WHO 1 st March 2013, Crest Golf Hotel.
Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.
Chronic diseases in HIV Francois Venter Wits Reproductive Health & HIV Institute
Know Your epidemic: The value of population-based household surveys Eva Kiwango Senior Strategic Information Advisor United Nations Joint Programme on.
“Getting to Zero: Thailand’s Experience with E-MTCT” Petchsri Sirinirund Advisor on HIV/AIDS Policy and Programme Department of Disease Control, Thailand.
UNAIDS, Regional Support Team, Eastern and Southern Africa
Dr. Yogan Pillay Deputy Director General National Department of Health, South Africa Monday 1 July 2013 OPERATIONAL AND PROGRAMMATIC CONSIDERATIONS IN.
Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Implications for Countries: Critical Issues in Service Delivery and Decision Making Dr. Yogan Pillay Deputy.
Possible solution: Change testing & care for patients in TB treatment Old system TB patient treated at TB center Referred to VCT center for HIV testing.
Impact evaluation Evaluate new tools Translate new knowledge into policy and implementation Knowledge gap Program implementation.
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
HIV in Suriname Ministry of Health Suriname M.Sigrid Mac Donald – Ottevanger, MD Focal point HIV Treatment and Care, NAP.
Surveillance to measure impact of ART Theresa Diaz, MD MPH CDC Global AIDS Program.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
LIMPOPO PROVINCIAL MEN’S SECTORS/BROTHERS FOR LIFE PRESENTED BY: RAPAKWANA JOHANNAH MANAGER:GAAP in HIV & AIDS & STIs Directorate DEPT OF HEALTH AND SOCIAL.
The Rationale for Option B+ in Malawi
Implementing antiretroviral therapy rollout to strengthen the health care system Dr Olive Shisana Human sciences Research Council.
MDG REPORT 2014 Progress towards achieving the MDGs.
IMPLEMENTATION PLAN TO SCALE UP HIV/AIDS PREVENTION AND TREATMENT 1.
Challenges of service integration: the TB model Linda-Gail Bekker The Desmond Tutu HIV Centre, Faculty of Health Sciences, University of Cape Town, South.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Treatment Last updated: December 2014.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
Models of Care for Paediatric HIV Miriam Chipimo MD MPH Reproductive Health & HIV&AIDS Manager, UNICEF, Malawi.
Enabling Continuity of a Public Health ARV Treatment program in a resource limited setting: The Case of the transition of the African Comprehensive HIV/AIDS.
2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.
6 th Biannual Joint HIV Sector Review Meeting Nov 11-13,2014 Ministry of Health and Social Welfare Mwanaisha Nyamkara, NTLP Werner Maokola, NACP Nov 11,
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Missed opportunities to diagnose TB and HIV Co-infection in HIV workplace program Dr Fred Mugyenyi Asiimwe Medical Director, ALAFA.
Monitoring UA 2010 in health sector 1 |1 | Monitoring progress towards Universal Access 2010 in the health sector Kevin M De Cock Ties Boerma.
Barriers to achieving the health MDGs and how these can be overcome Action for Global Health UK Policy Conference London, 28 June 2010 Isabelle de Zoysa.
Integrating ART/PMTCT services into MNCH services to enhance test & treat strategy for HIV infected pregnant and lactating women (Option B+) WHO Satellite.
IAS Policy and Advocacy priority on Treatment as Prevention Carlos F. Cáceres Multidisciplinary Research on ARV-based Prevention 30 June 2013 Kuala Lumpur.
Providing Treatment, Restoring Hope Program Updates Dr. Robb Sheneberger, MD University of Maryland School of Medicine Track 1.0 Implementers Meeting Dar.
Provider initiated testing in Kenya Ruth Nduati Associate Prof Paediatrics University of Nairobi.
Africa Regional Meeting on Interventions for Impact in EmOC Feb 2011, Addis Ababa Maternal and Newborn Health in the African Region Africa Regional.
Understanding temporal trends in HIV prevalence, incidence and ARV Dr Valerie Delpech Head of HIV surveillance Public Health England.
MDG 4 Target: Reduce by two- thirds, between 1990 & 2015, the mortality rate of children under five years.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
An update on HIV prevention and treatment Prof Francois Venter Wits Reproductive Health and HIV Institute (WRHI) University of the Witwatersrand Oct 2012.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
STRATEGIC INFORMATION FOR ACTION IN VIET NAM 6 th Viet Nam National Scientific Conference 24 November 2015 Ha Noi, Viet Nam Amitabh Bipin SUTHAR, PharmD,
Fast-Tracking Treatment to End AIDS ICASA Ambassador Deborah Birx, MD U.S. Global AIDS Coordinator November 30, 2015.
STATE OF THE EPIDEMIC AND THE RESPONSE PROMISES, PROGRESS AND PROBLEMS DR. ALEX COUTINHO MD MPH Executive Director Infectious Diseases Institute.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Moving from a commodity approach: “Fund some of everything” or “Fund what is comfortable” to An Investment approach: “Fund evidenced-based activities.
Contents - HIV global slides
Contents Global impact 2.Service cascade 3. Policies and WHO support.
TB/ HIV CONTROL AND MANAGEMENT IN SOUTH AFRICA
Pregnancy and living with HIV
Entry into care Failure to initiate timely HIV care after diagnosis is common ~75% of newly diagnosed link to care within 6-12 months Delayed entry into.
Palliative Care and M/XDR-TB Global burden of M/XDR-TB
World Health Organization
Cross-sectional assessment of patient outcomes using a systematic file review process: Results from 12,987 patient files Ambereen Jaffer, Gesine Meyer-Rath,
The use of cotrimoxazole prophylaxis in the context of HIV infection
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
WHO HIV update July 2018 Global epidemic Global progress and cascade
TB-HIV Last updated: November 2018.
Contents - HIV global slides
Contents - HIV global slides
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
Contents - HIV global slides
South Africa: From ProTest to Nationwide Implementation
From ProTEST to Nationwide Implementation
Contents Global impact 2.Service cascade 3. Policies and WHO support.
Why Quality Matters in ART Programs
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

Getting to 80% ART coverage Dr Francois Venter Reproductive Health and HIV Research Unit University of the Witwatersrand January 2010 Thanks to: Robin Wood

HIV and South Africa 5 million people

Eastern & Southern Africa 1.5 million (57% Rest of the world 1.2 million (43%) Global new infections, 2.7 million ESA new infections, Prov. estimate 1.5m Estimates of New Infections in Eastern and Southern Africa, 2007

South Africa: Why is it important? Size of the country; size of the epidemic; size of ART programme Rich country! De Cock: If South Africa fails, we all fail

The proportion of deaths due to AIDS has shown a staggering increase in the last decade 97% 3% 28% 54% 46%AIDS implicated % Source: ASSA2003 Model Stats SA 2009: 43% directly due to AIDS Common, preventable, treatable… How is it not a public health priority?

 Review of data from from 176 sites in 42 countries (N = 33,008) When Is Antiretroviral Therapy Started? Egger M, et al. CROI Abstract 62.

High death rate while waiting for ART Arch Intern Med 2008;1678:86 Braitstein, P et al. High Risk Express Care: a novel care model to reduce early mortality among high risk HIV- infected patients initiating combination antiretroviral treatment. HIV Implementers Meeting, Namibia, abstract 1556, June Expedited care decreased mortality by 60%

“"There is a need for honesty and peer review in situations that impact public health policy. When AIDS denialism enters public health practice, the consequences are tragic. The implications start in honest science but extend to the need for accountability and, perhaps, public health reform." Chigwedere P, Essex M. AIDS Denialism and Public Health Practice. AIDS and Behavior, 2010; DOI: /s

Outcomes of ART 5 year survival on ART in Botswana 88.6% (88.1 – 89.2) Puvimanasinghe JPA et al. Mexico 2008 (MOAB0204) ART recipients do well!

How are we doing?

Somewhere around 45% in 2009… (NOT retention in care!)

Who did we NOT reach? Proportion of children reached probably similar

need ARV’s EACH year well on ARV’s dead

Our models: 1 hospitalisation, 2-3 clinic visits per person put on ART “Test and treat” modellers – 2-9 days hospitalisation averted per person on ART Hugely cost saving in SA WHATEVER CD4 you use (in Kenya, not so)

Can we achieve scale-up?

RHRU programme? Urban and rural: Initiation CD since 2004 Johannesburg inner city – average CD4 106, despite 70% coverage, and massive escalation of HIV testing ¼ of all South Africans had an HIV test in 2008 (Shisana, HSRC Mandela survey, 2009)

Number of Patients initiated on to RHRU Supported Sites within Region F

The famous cascade… 50% loss to follow up at EVERY step

Target setting Not even done at a provincial level Starts with HIV testing – but EVERY step needs to be counted

Paediatrics Decent maternal ART=unemployed HIV paediatricians BUT hard to identify, hard to treat Suffer the most in poor health systems Prevention is better than treatment

Task shifting Cost of SA health care workers is very high Excuse for not scaling up, despite relatively high staffing levels Paradoxically, meant that task shifting has not happened

TB… Thanks: Braamie Variava

Highest TB incident and prevalence % ,000 1,100 1, Incidence of TB per 100,000 population MDG 2015 Target 56 Source: Health Systems Trust reported 722 number; WHO: Global Tuberculosis Control, Surveillance, Planning, Financing reported 940 TB-HIV co-infection was approximately 55% in 2002 The number of people diagnosed with TB trebled between 1996 and 2006 (from 269 to 720 cases of TB per ) 900 cases of Extensive Drug Resistant TB were reported between 2004 and 2007

ART best way to prevent TB IPT very hard to implement

The role of donors History – confrontational Patch up the gaping holes in the programme Now: sustainability and technical ability – ESPECIALLY critical reviews of data and resource usage

In summary: We’re still treating HIV as an acute illness Mortality is driven by late diagnosis, poor referral, and delayed ART – we aren’t acting urgently post diagnosis People who get ART, generally stay on it DESPITE the system (commonest reason for LTFU – changing jobs) Adherence is good, but failures are costly

What would I do? Quick and (relatively) easy: TDF, FDC’s, use tender process to get better deals on drug packaging, PMTCT ANC and TB clinics to test and start ART Programmatically hard: Targets for every step – starting with the provinces, down to a clinical level Creative and expensive: Chronic disease grants, medicine pick ups Expand HIV testing in health facilities Critically review certain programmes for LTFU – ‘know your status’ not good enough Review SANAC

The two elephants in the room Health systems and retention in care The average South African does not want to attend a state health facility (for good reason!) Retention in care affects – OI prophylaxis, IPT, ‘prevention for positives’, discordant couple interventions, etc etc ? A chronic care system is the silo we need Finally: Public health leadership – tough choices, tough priority setting – focus on using existing resources more intelligently